BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 31118602)

  • 1. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 2. Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2139-2146. PubMed ID: 30034229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
    Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
    Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of Chronic Obstructive Pulmonary Disease on Risk of Recurrence in Patients with Resected Non-small Cell Lung Cancer].
    Qiang G; Yu Q; Liang C; Song Z; Shi B; Guo Y; Liu D
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):215-220. PubMed ID: 29587946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
    Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
    Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
    Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
    Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic impact of obstructive lung disease on survival of never smokers with resected non-small-cell lung cancer: a comparison with smokers.
    Akamine T; Tagawa T; Shimokawa M; Matsubara T; Kozuma Y; Haratake N; Takamori S; Toyokawa G; Maehara Y
    Interact Cardiovasc Thorac Surg; 2019 May; 28(5):735-743. PubMed ID: 30602039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
    Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
    Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
    Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
    J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic obstructive pulmonary disease on postoperative recurrence in patients with resected non-small-cell lung cancer.
    Qiang G; Liang C; Xiao F; Yu Q; Wen H; Song Z; Tian Y; Shi B; Guo Y; Liu D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():43-9. PubMed ID: 26766906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.
    Dong W; Du Y; Ma S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3805-3812. PubMed ID: 30538442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
    J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
    Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
    Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.